TL;DR: The Centers for Medicare & Medicaid Services modified NCD 358 governing PILD (percutaneous image-guided lumbar decompression) coverage, with an effective date of 2026-03-04. Coverage remains restricted to beneficiaries enrolled in approved clinical studies under Coverage with Evidence Development (CED). Here's what billing teams need to know.
CMS PILD coverage policy under NCD 358 has not opened up broad Medicare reimbursement for this procedure. If your practice or facility bills for lumbar spinal stenosis treatments, this update matters. The policy does not list specific CPT or HCPCS codes, which creates real documentation and claim submission challenges your billing team needs to address now.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Percutaneous Image-Guided Lumbar Decompression for Lumbar Spinal Stenosis |
| Policy Code | NCD 358 |
| Change Type | Modified |
| Effective Date | 2026-03-04 |
| Impact Level | High |
| Specialties Affected | Interventional Pain Management, Spine Surgery, Orthopedic Surgery, Neurosurgery, Outpatient Hospital Facilities |
| Key Action | Confirm active CED study enrollment before billing any PILD procedure for Medicare beneficiaries |
CMS PILD Coverage Criteria and Medical Necessity Requirements 2026
The real issue with NCD 358 Medicare coverage is this: PILD is not covered as a standard Medicare benefit. The Centers for Medicare & Medicaid Services covers PILD only through Coverage with Evidence Development, meaning your patient must be enrolled in a qualifying clinical study before any claim has a shot at reimbursement.
This is a CED-only coverage policy. That distinction is not a technicality — it's the entire framework governing payment. If a patient isn't enrolled in an approved study meeting NCD 358 criteria, the claim will be denied. Full stop.
What Is PILD?
PILD is a posterior decompression of the lumbar spine. It's performed under indirect image guidance — fluoroscopic or CT — without direct visualization of the surgical area.
The procedure uses specially designed instruments to percutaneously remove part of the lamina and reduce the size of the ligamentum flavum. Contrast media and epiduragram confirm and monitor the compressed area. CMS describes this as a treatment for symptomatic lumbar spinal stenosis (LSS) unresponsive to conservative therapy.
Medical Necessity Under CED
For PILD billing to meet medical necessity under this coverage policy, two conditions must be true simultaneously. First, the patient has LSS that has not responded to conservative therapy. Second, the patient is actively enrolled in a CMS-approved clinical study.
Meeting just the clinical criterion isn't enough. The study enrollment requirement is non-negotiable for Medicare payment.
What the Approved Study Must Cover
CMS has specific research questions it wants these studies to answer. A qualifying study must address at least one of the following:
| # | Covered Indication |
|---|---|
| 1 | Does PILD provide a clinically meaningful improvement in function and/or quality of life compared to other LSS treatments? |
| 2 | Does PILD provide clinically meaningful pain reduction compared to other treatments? |
| 3 | Does PILD affect overall clinical management and decision-making for LSS, including use of other medical services? |
The study design must be prospective, randomized, and controlled. It must use validated measurement instruments and clinically appropriate comparators — including medical or surgical interventions or a sham-controlled arm for the non-PILD group.
Study Protocol Requirements for CMS Approval
CMS requires the study protocol to specify a statistical analysis plan and a minimum patient follow-up period. The protocol must evaluate how patient characteristics affect health outcomes and how long any benefit lasts.
Beyond clinical design, the study must meet these criteria:
| # | Covered Indication |
|---|---|
| 1 | The principal purpose is to test whether PILD improves patient health outcomes |
| 2 | The study is well-supported by existing scientific and medical information, or it clarifies outcomes of interventions already in common clinical use |
| 3 | The study does not duplicate existing research without justification |
| 4 | The design is appropriate for the research question |
| 5 | The sponsoring organization is capable of executing the study successfully |
| 6 | The study complies with all applicable federal regulations for human subject protection under 45 CFR Part 46 |
If the study is regulated by the FDA, it must also comply with FDA regulations for human subject protection.
Prior Authorization and CED Enrollment
This policy doesn't frame coverage in terms of traditional prior authorization. The CED enrollment requirement functions like a permanent prior authorization gate. Before any PILD procedure on a Medicare beneficiary, you need documented proof of study enrollment. Without that documentation, your claim has no path to payment.
If your facility is considering participating in a PILD study, talk to your compliance officer before the effective date. The study approval process through CMS involves its own documentation and qualification steps that sit entirely outside normal billing workflows.
CMS PILD Exclusions and Non-Covered Indications
PILD performed outside an approved clinical study is not covered under Medicare. This applies regardless of the patient's clinical presentation or how severe their LSS is.
The policy does not carve out exceptions for patients who might be "good candidates" based on clinical judgment alone. CMS has explicitly determined that the evidence base for PILD does not yet support broad coverage. That's the entire rationale for the CED framework.
PILD billing for Medicare beneficiaries outside a qualifying study will generate a claim denial. There's no appeal argument that overcomes the absence of study enrollment.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| LSS unresponsive to conservative therapy — patient enrolled in CMS-approved CED study | Covered | Not specified in NCD 358 | Study must meet prospective, randomized, controlled design requirements; effective for services on or after January 9, 2014 |
| LSS — patient NOT enrolled in an approved CED study | Not Covered | Not specified in NCD 358 | No exceptions; claim will be denied regardless of clinical severity |
| PILD performed outside prospective, randomized, controlled study framework | Not Covered | Not specified in NCD 358 | Observational studies or registries alone do not qualify |
CMS PILD Billing Guidelines and Action Items 2026
PILD billing under NCD 358 is narrow, and the margin for error is small. These are the steps your billing and revenue cycle team should take now, ahead of the March 4, 2026 effective date.
| # | Action Item |
|---|---|
| 1 | Audit every open PILD claim for CED study enrollment documentation. If you can't produce a study enrollment record for a Medicare beneficiary, that claim is at risk. Pull all open and recently submitted PILD claims and verify documentation before March 4, 2026. |
| 2 | Confirm your facility is participating in a CMS-approved study — not just any clinical trial. The study must meet the specific design criteria in NCD 358: prospective, randomized, controlled, with validated measurement instruments. Enrollment in an IRB-approved trial doesn't automatically satisfy CMS requirements. Verify the study's CMS approval status directly. |
| 3 | Update your intake and scheduling workflows to flag Medicare PILD patients before the procedure date. Your front-end team should confirm study enrollment at scheduling, not at billing. A claim submitted without enrollment documentation creates write-off risk and appeals burden. Build the check into your pre-service workflow. |
| 4 | Contact your Medicare Administrative Contractor (MAC) to confirm any local billing guidelines that apply to PILD claims in your region. NCD 358 is a national coverage determination, but your MAC may have additional documentation or coding requirements. Don't assume the NCD is the only standard you're working against. |
| 5 | Clarify which codes to use on PILD claims with your MAC, since NCD 358 does not specify CPT or HCPCS codes. This is not a minor gap. The absence of listed codes in the policy means your billing team needs to identify the correct codes through MAC guidance, industry coding references, or your compliance officer. Submitting the wrong code — even with correct documentation — creates claim denial exposure. |
| 6 | Document conservative therapy failure thoroughly in the medical record before the procedure. "Unresponsive to conservative therapy" is a coverage criterion, and CMS auditors will look for evidence. Vague notes won't hold up. The record should show what was tried, for how long, and why it didn't work. |
| 7 | Loop in your compliance officer before billing any PILD procedure for the first time under this updated policy. The combination of CED-only coverage, absent codes, and MAC-level variation makes this a policy where self-directed billing decisions carry real risk. Get compliance involved early. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for PILD Under NCD 358
Covered CPT and HCPCS Codes
NCD 358 does not list specific CPT or HCPCS codes. This is a significant gap in the policy as written.
Your billing team cannot rely on the NCD alone to determine which procedure codes to use for PILD claims. Contact your MAC directly to get guidance on the appropriate codes for PILD procedures performed under a qualifying CED study.
Document whatever guidance your MAC provides. You want a paper trail if a claim is denied and you need to appeal.
Key ICD-10-CM Diagnosis Codes
NCD 358 does not list specific ICD-10-CM diagnosis codes. The policy references lumbar spinal stenosis (LSS) as the covered diagnosis condition. Work with your coding team and MAC to confirm the appropriate ICD-10-CM codes — such as codes within the M48.0x spinal stenosis category — for PILD claims under this NCD.
Do not bill ICD-10 codes without confirming they align with your MAC's PILD billing guidance. The absence of codes in the NCD is not permission to use any LSS code — it's a signal that you need to verify before you bill.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.